Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/176523
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFranco Fernández, Rafael-
dc.contributor.authorReyes Resina, Irene-
dc.contributor.authorNavarro Brugal, Gemma-
dc.date.accessioned2021-04-20T14:56:01Z-
dc.date.available2021-04-20T14:56:01Z-
dc.date.issued2021-01-22-
dc.identifier.issn2227-9059-
dc.identifier.urihttp://hdl.handle.net/2445/176523-
dc.description.abstractDopamine is derived from an amino acid, phenylalanine, which must be obtained through the diet. Dopamine, known primarily to be a neurotransmitter involved in almost any higher executive action, acts through five types of G-protein-coupled receptors. Dopamine has been studied extensively for its neuronal handling, synaptic actions, and in relation to Parkinson's disease. However, dopamine receptors can be found extra-synaptically and, in addition, they are not only expressed in neurons, but in many types of mammalian cells, inside and outside the central nervous system (CNS). Recent studies show a dopamine link between the gut and the CNS; the mechanisms are unknown, but they probably require cells to act as mediators and the involvement of the immune system. In fact, dopamine receptors are expressed in almost any cell of the immune system where dopamine regulates various processes, such as antigen presentation, T-cell activation, and inflammation. This likely immune cell-mediated linkage opens up a new perspective for the use of dopamine-related drugs, i.e., agonist--
dc.format.extent13 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/biomedicines9020109-
dc.relation.ispartofBiomedicines, 2021, vol. 9, num. 2, p. 109-
dc.relation.urihttps://doi.org/10.3390/biomedicines9020109-
dc.rightscc-by (c) Franco Fernández, Rafael et al., 2021-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Bioquímica i Biomedicina Molecular)-
dc.subject.classificationDopamina-
dc.subject.classificationNeurotransmissors-
dc.subject.classificationMalalties-
dc.subject.otherDopamine-
dc.subject.otherNeurotransmitters-
dc.subject.otherDiseases-
dc.titleDopamine in health and disease: much more than a neurotransmitter-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec710916-
dc.date.updated2021-04-20T14:56:01Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid33499192-
Appears in Collections:Articles publicats en revistes (Bioquímica i Biomedicina Molecular)
Articles publicats en revistes (Bioquímica i Fisiologia)

Files in This Item:
File Description SizeFormat 
710916.pdf1.57 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons